Real-Time Oncology Review (RTOR) by FDA: Fast-Tracking Cancer Drug Approvals
Real-Time Oncology Review (RTOR) by FDA: Fast-Tracking Cancer Drug Approvals Accelerating Cancer Drug Approvals with the FDA Real-Time Oncology Review (RTOR) The U.S. Food and Drug Administration (FDA) has introduced several innovative regulatory pathways to expedite drug approvals, especially in high-need areas like oncology. One such initiative is the Real-Time Oncology Review (RTOR), designed to…
Read More “Real-Time Oncology Review (RTOR) by FDA: Fast-Tracking Cancer Drug Approvals” »